Health
·
ThisDay
·
Cuba Advances Home-grown Cancer Drug as 2C12 Enters Human Trials
Cuba is advancing development of 2C12, a home-grown cancer drug that has reached human clinical trials. The milestone marks a significant stage in testing the treatment’s potential and reflects the country’s efforts to develop locally produced medical therapies for cancer care.
Original story
Continue reading on ThisDay.
facts.ng aggregates publicly available headlines and provides AI-generated summaries. The original article is published by ThisDay; please visit them for the full report.